An open Label, Multicentre, Phase Study of Ibrutinib, Rituximab and EBV specific T-cells in Patients with EBV-positive Primary or Secondary CNS LYMPHOMA unsuitable for standard therapies

  • Gandhi, Maher (Chief Investigator)
  • Cheah, Chan (Investigator 02)
  • Dolcetti, Riccardo (Investigator 03)
  • Polizzotto, Mark (Investigator 04)
  • Keane, Colm (Investigator 05)
  • Mollee, Peter (Investigator 06)
  • Slavin, Monica (Investigator 07)
  • Teh, Benjamin (Investigator 08)
  • Krause, Lutz (Investigator 09)
  • Scuffham, Paul (Investigator 10)

    Project Details

    StatusActive
    Effective start/end date1/12/2015/11/24

    Funding

    • Medical Research Future Fund MRFF